Seed Health became profitable by selling consumer probiotics, and now it's chasing much bigger science, investing in an AI platform for microbiome moonshots. Read this story
Seed Health became profitable by selling consumer probiotics, and now it's chasing much bigger science, investing in an AI platform for microbiome moonshots. Read this story
More from CNBC | Health care industry Biotech and Pharmaceuticals Biotechnology Science business news cnbc Articles Equity and Opportunity Health & Science Life Sciences Business News Media CNBC Changemakers source:tagname:CNBC US Source